Understanding progressive rubella pan encephalitis: a rare neurological disorder
DOI:
https://doi.org/10.18203/2320-6012.ijrms20242256Keywords:
Rubella, Panencepalitis, SSPE, Congenital rubella syndromeAbstract
Progressive rubella panencephalitis (PRP) is a rare late complication of rubella that affects mainly teenagers. It is characterized by progressive white matter destruction, gliosis and cerebral atrophy, similar to subacute sclerosing panencephalitis (SSPE) and congenital rubella syndrome. This paper examines the complexity of PRP, its clinical manifestations, pathogenesis, diagnostic criteria, treatment and prophylaxis. PRP should be considered in adolescents with progressive dementia with pyramidal and cerebral dysfunction. With respect to the most affected children, survival and recovery is expected to be poor, with high mortality rates, especially in the first six months of life. The development of progressive spasticity, ataxia, mental deterioration and convulsions in late childhood and early childhood with mothers' rubella or stigmata histories is the subject of research on PRP. Therefore, continued efforts to understand and address PRP are important to improve the quality of diagnosis, treatment and ultimately the quality of life of affected persons.
Metrics
References
World Health Organization. Rubella. 2020. Available at: https://www.who.int/news-room/fact-sheets/detail/rubella. Accessed on 09 May 2024.
Centers for Disease Control and Prevention. Progressive Rubella Panencephalitis. 2019. Available at: https://www.cdc.gov/vaccines/pubs/ pinkbook/rubella.html. Accessed on 09 May 2024.
Townsend JJ, Baringer JR, Wolinsky JS, Malamud N, Mednick JP, Panitch HS, et al. Progressive Rubella Panencephalitis. N Engl J Med. 1975;292(19):990-3.
Abe T, Date M. Rubella virus. Nihon Rinsho. Japanese J Clin Med. 1997;55(4):865-9.
Wolinsky JS, Berg BO, Maitland CJ. Progressive rubella panencephalitis. Arch Neurol. 1976;33(10):722-3.
Weil ML, Itabashi HH, Cremer NE, Oshiro LS, Lennette EH, Carnay L. Chronic progressive panencephalitis due to rubella virus simulating subacute sclerosing panencephalitis. N Engl J Med. 1975;292(19):994-8.
Chaari A, Bahloul M, Berrajah L, Kahla SB, Gharbi N, Karray H, et al. Childhood rubella encephalitis: diagnosis, management, and outcome. J Child Neurol. 2014;29(1):49-53.
Frey TK. Neurological Aspects of Rubella Virus Infection. Intervirology. 1997;40(2-3):167-75.
Sawlani V, Shankar JJ, White C. Magnetic resonance imaging findings in a case of congenital rubella encephalitis. Canad J Infect Dis Med Microbiol. 2013;24(4):e122.
Townsend JJ, Wolinsky JS, Baringer JR. The neuropathology of progressive rubella panencephalitis of late onset. Brain. 1976;99(1):81-90.
Booss J. Types of immunological failure in the “slow-virus” encephalopathies and multiple sclerosis. Yale J Biol Med. 1980;53(1):101-7.
Tesini BL. Progressive Rubella Panencephalitis. 2023. Available at: https://www.msdmanuals. com/en-in/professional/pediatrics/common-viral-infections-in-infants-and-children/progressive-rubella-panencephalitis. Accessed on 09 May 2024.
Centres for Disease Control and Prevention. Rubella (German Measles) Vaccination. Available at: https://www.cdc.gov/vaccines/vpd/rubella/index.html. Accessed on 09 May 2024.